BRIEF published on 03/27/2025 at 19:17, 13 days 9 hours ago Advicenne Reports Solid Growth and Future Plans for 2025 Cash Flow Improvement 2025 Outlook Advicenne Financial Results Sibnayal Sales Growth ADV7103 Regulatory Progress
BRIEF published on 03/27/2025 at 19:17, 13 days 9 hours ago Advicenne annonce une croissance solide et des projets futurs pour 2025 Amélioration Des Flux De Trésorerie Perspectives 2025 Résultats Financiers D'Advicenne Croissance Des Ventes De Sibnayal Progrès Réglementaires ADV7103
PRESS RELEASE published on 03/27/2025 at 19:12, 13 days 9 hours ago Inside Information / News release on accounts, results Advicenne reports successful commercial performance of Sibnayal® in Europe, with total product sales up 9.4% to €4.9m. Major strides in US development with NDA filing expected in Q3 2025 Financial Results Advicenne Commercial Performance Sibnayal US Development
PRESS RELEASE published on 03/27/2025 at 19:12, 13 days 9 hours ago Informations privilégiées / Communiqué sur comptes, résultats Advicenne annonce ses résultats annuels 2024 avec un chiffre d'affaires en hausse de 9,4% grâce à Sibnayal® en Europe; avancées réglementaires majeures aux Etats-Unis Chiffre D'affaires Résultats Annuels États-Unis Advicenne Sibnayal
BRIEF published on 10/01/2024 at 07:05, 6 months 8 days ago Advicenne progresse aux États-Unis avec des avis positifs de la FDA sur ADV7103 FDA Advicenne ADV7103 ATRd Cystinurie
BRIEF published on 10/01/2024 at 07:05, 6 months 8 days ago Advicenne Advances in US with Positive FDA Reviews for ADV7103 FDA ADV7103 ATRd Advicenna Cystinuria
PRESS RELEASE published on 10/01/2024 at 07:00, 6 months 8 days ago Informations privilégiées / Autres communiqués Advicenne franchit des étapes majeures aux Etats-Unis pour ADV7103 avec des avis favorables de la FDA, ouvrant des opportunités partenariales, simplifiant les démarches réglementaires et cliniques FDA Développement États-Unis Partenaires Advicenne
PRESS RELEASE published on 10/01/2024 at 07:00, 6 months 8 days ago Inside Information / Other news releases Advicenne achieves major milestones in the US with positive FDA opinions on ADV7103, accelerating partnership outlook for commercialization, preparing for clinical development in cystinuria, and seeking commercial partners Commercialization Advicenne ADV7103 Cystinuria FDA Opinions
BRIEF published on 05/15/2024 at 09:07, 10 months 25 days ago Advicenne Shareholders Approve Board-Supported Resolutions at General Meeting Euronext Growth Paris Pharmaceutical Industry General Meeting Advicenne Rare Renal Diseases
BRIEF published on 05/15/2024 at 09:07, 10 months 25 days ago Les actionnaires d'Advicenne approuvent les résolutions soutenues par le conseil d'administration lors de l'assemblée générale Assemblée Générale Euronext Croissance Paris Industrie Pharmaceutique Conseille Maladies Rénales Rares
Published on 04/10/2025 at 02:30, 2 hours 31 minutes ago Star Copper Completes Non-Brokered Private Placement for Proceeds of $2,500,000
Published on 04/09/2025 at 23:30, 5 hours 31 minutes ago AirIQ Announces Major Customer Win Accelerating Growth in Recurring Revenue
Published on 04/09/2025 at 22:17, 6 hours 44 minutes ago Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details
Published on 04/09/2025 at 22:05, 6 hours 56 minutes ago Amdocs Announces Q3F25 Investor Conference Schedule
Published on 04/10/2025 at 04:55, 6 minutes ago CO2Coin one of the most successful crypto investments of the coming decades.
Published on 04/09/2025 at 20:20, 8 hours 41 minutes ago Zimbabwe Government Delivers on Commitment: Compensation of Former Farm Owners under the Global Compensation Deed Commences
Published on 04/09/2025 at 20:18, 8 hours 43 minutes ago EQS-Adhoc: VOLKSWAGEN AKTIENGESELLSCHAFT: Volkswagen AG publishes preliminary key figures for the financial statements as of March 31, 2025
Published on 04/09/2025 at 19:08, 9 hours 52 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/09/2025 at 18:45, 10 hours 16 minutes ago EUROPLASMA: Précisions dans le cadre du projet de reprise de la Fonderie de Bretagne
Published on 04/09/2025 at 18:59, 10 hours 1 minute ago Description of the 2025-2026 Share Buyback Program
Published on 04/09/2025 at 18:59, 10 hours 1 minute ago Descriptif du programme de rachat d'actions 2025-2026
Published on 04/09/2025 at 18:57, 10 hours 3 minutes ago Minutes of the Combined General Meeting held on April 9, 2025
Published on 04/09/2025 at 18:57, 10 hours 3 minutes ago Compte-rendu de l'Assemblée Générale Mixte du 9 avril 2025
Published on 04/09/2025 at 17:45, 11 hours 16 minutes ago COGELEC : Résultats annuels 2024 et Chiffre d’affaires du 1 er trimestre 2025.
